OUR MISSION:
To partner with healthcare providers, payers, patients and advocacy groups to eradicate colorectal cancer.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

Employee Q&A: What It Takes To Get Results

Exact Sciences is recruiting heavily in an effort support the launch of Cologuard and development of our product pipeline. To support this effort, we'll be publishing Q&As with Exact team members in the areas we are hiring. This interview features Emily Bowe, a new member of our growing laboratory team. As part of her role as a Laboratory Scientist, Emily helps...Read more

Exact Sciences’ Stool DNA Screening Technology Featured in Posters at Digestive Disease Week 2015

WASHINGTON-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that data supporting its stool DNA (sDNA) screening platform for colorectal cancer and other screening techniques for the detection of additional gastrointestinal cancers and diseases will be presented in five posters at Digestive Disease Week (DDW) 2015, taking place May 16-19 in Washington...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com

FOR OUR INVESTORS

View updates on upcoming conference appearances, company news, financial reports and more.

Learn More